Portfolio

*WHO licensure prequalification

Vaccines(Vx), Therapeutics(Tx)
Focus field	Project title	Research institute	Development stage
Focus field	Project title	Research institute	Preclin-ical	Phase1	Phase2	Phase3	Licens-ure
Vaccines (Vx)	Low-cost HepAVaccine Manufacturing Platform		●
	Novel Cholera Conjugate Vaccine			●
	Pentavalent Meningitis Conjugate Vaccine			●	●	●
	Prime-Boost BCG Vaccine		●
	Development of a sublingual COVID-19 subunit vaccine		●
	Schistosomiasis vaccine			●	●
	Typhoid Conjugate Vaccine				●	●
Therapeutics (Tx)	Continuous Manufacturing Process for New Antimalarial		●	●
	Antimalarial combination therapy for malaria prevention			●	●
	Development of a therapeutic anti-dengue polymeric IgG antibody		●
	Continuous manufacturing process for visceral leishmaniasis drug			●

Diagnostics(Dx), Digital Health(DH)
Focus field	Project title	Research institute	Development stage
Focus field	Project title	Research institute	Early Validation	Late Validation	Clinical Validation	Licens-ure
Diagnostics (Dx)	Leishmaniasis RDT Cartridge and Mobile Pocket Analyzer		●
	2nd Generation TB LAM Assay			●	●
	AI-driven All-in-One Diagnostic platform for Malaria Species Differentiation			●	●
	In vitro Diagnostics Test for Severe Fever and thrombocytopenia Syndrome			●
	POCT for Pyrazinamide (PZA) Susceptibility Testing		●
	POCT for Multidrug-Resistant TB			●	●

*WHO licensure prequalification

Vaccines(Vx)
Project title	Research institute	Development stage					Current state
Project title	Research institute	Preclin-ical	Phase1	Phase2	Phase3	Licens-ure	Current state
DTwP-HepB-Hib Pentavalent MAP Vaccine		●					Completed
Low-cost HepAVaccine Manufacturing Platform		●					In progress
Novel Cholera Conjugate Vaccine		●					Completed
Prime-Boost BCG Vaccine		●					In progress
COVID-19 Vaccine Using Viral Vector System		●					Completed
DNA Vaccine Using Electro-Portable MicroneedlePatch			●				Completed
Intranasal Universal Respiratory Virus Vaccine		●					Completed
Microneedle-mediated SARS-CoV-2 DNA Vaccine		●					Completed
Mpg loaded TB MAP Vaccine		●					Completed
Non-replicating Protein Nanoparticles-based Rotavirus Vaccine		●					Completed
SARS-CoV-2 Nanogel Sublingual Vaccine		●					Suspended
Virus-free Recombinant Polio Vaccine		●					Suspended
Development of a sublingual COVID-19 subunit vaccine		●					In progress
Novel Cholera Conjugate Vaccine			●				In progress
Quadrivalent Meningitis Conjugate Vaccine			●	●	●		Suspended
Pentavalent Meningitis Conjugate Vaccine			●	●	●		In progress
Schistosomiasis vaccine			●	●			In progress
DTwP-HepB-IPV-Hib Hexavalent Vaccine				●	●		Completed
Typhoid Conjugate Vaccine				●	●		In progress

*WHO licensure prequalification

Vaccines(Vx)
Project title	Research institute	Development stage
Project title	Research institute	Preclin-ical	Phase1	Phase2	Phase3	Licens-ure
DTwP-HepB-Hib Pentavalent MAP Vaccine		●
Novel Cholera Conjugate Vaccine		●
COVID-19 Vaccine Using Viral Vector System		●
DNA Vaccine Using Electro-Portable MicroneedlePatch			●
Intranasal Universal Respiratory Virus Vaccine		●
Microneedle-mediated SARS-CoV-2 DNA Vaccine		●
Mpg loaded TB MAP Vaccine		●
Non-replicating Protein Nanoparticles-based Rotavirus Vaccine		●
DTwP-HepB-IPV-Hib Hexavalent Vaccine				●	●

*WHO licensure prequalification

Vaccines(Vx)
Project title	Research institute	Development stage
Project title	Research institute	Preclin-ical	Phase1	Phase2	Phase3	Licens-ure
Low-cost HepAVaccine Manufacturing Platform		●
Novel Cholera Conjugate Vaccine			●
Pentavalent Meningitis Conjugate Vaccine			●	●	●
Prime-Boost BCG Vaccine		●
Development of a sublingual COVID-19 subunit vaccine		●
Schistosomiasis vaccine			●	●
Typhoid Conjugate Vaccine				●	●

*WHO licensure prequalification

Vaccines(Vx)
Project title	Research institute	Development stage
Project title	Research institute	Preclin-ical	Phase1	Phase2	Phase3	Licens-ure
SARS-CoV-2 Nanogel Sublingual Vaccine		●
Virus-free Recombinant Polio Vaccine		●
Quadrivalent Meningitis Conjugate Vaccine			●	●	●

*WHO licensure prequalification

Therapeutics(Tx)
Project title	Research institute	Development stage					Current state
Project title	Research institute	Preclin-ical	Phase1	Phase2	Phase3	Licens-ure	Current state
Development of a therapeutic anti-dengue polymeric IgG antibody		●					In progress
NiclosamideIntramuscularDepotInjectionfor Dengue VirusDisease		●					Suspended
Safety assessment of TTCA antitubercular agents		●					Completed
Novel route of synthesis of antimalarial drug		●	●				Suspended
Antimalarial combination therapy for malaria prevention			●	●			In progress
Continuous manufacturing process for visceral leishmaniasis drug			●				In progress
Continuous Manufacturing Process for New Antimalarial				●	●		In progress

*WHO licensure prequalification

Therapeutics(Tx)
Project title	Research institute	Development stage
Project title	Research institute	Preclin-ical	Phase1	Phase2	Phase3	Licens-ure
Safety assessment of TTCA antitubercular agents		●

*WHO licensure prequalification

Therapeutics(Tx)
Project title	Research institute	Development stage
Project title	Research institute	Preclin-ical	Phase1	Phase2	Phase3	Licens-ure
Antimalarial combination therapy for malaria prevention			●	●
Novel route of synthesis of antimalarial drug				●	●
Development of a therapeutic anti-dengue polymeric IgG antibody		●
Continuous manufacturing process for visceral leishmaniasis drug			●

*WHO licensure prequalification

Therapeutics(Tx)
Project title	Research institute	Development stage
Project title	Research institute	Preclin-ical	Phase1	Phase2	Phase3	Licens-ure
NiclosamideIntramuscularDepotInjectionfor Dengue VirusDisease		●
Novel route of synthesis of antimalarial drug		●	●

*WHO licensure prequalification

Diagnostics(Dx)
Project title	Research institute	Development stage				Current state
Project title	Research institute	Early Validation	Late Validation	Clinical Validation	Licens-ure	Current state
Leishmaniasis RDT Cartridge and Mobile Pocket Analyzer		●				In progress
In vitro Diagnostics Test for Severe Fever and thrombocytopenia Syndrome			●			In progress
Instrument-free molecular diagnostic platform for COVID-19		●	●			Completed
Mobile Diagnostic Platform for Influenza and SARS-CoV-2		●	●			Completed
POCT for Pyrazinamide (PZA) Susceptibility Testing		●				In progress
Quantitative POC Test Using mBFPfor G6PD Deficiency		●				Completed
Rapid Diagnostic Test for Both S.Typhiand S.ParatyphiA		●	●			Suspended
Rapid Diagnostic Test for Chikungunya Antigen		●				Completed
Rapid Diagnostic Test for Visceral Leishmaniasis Antigen		●				Suspended
SurearlySmartPro COVID-19		●				Completed
2nd Generation G6PD Test			●	●		Completed
2nd Generation TB LAM Assay			●	●		In progress
POCT for Multidrug-Resistant TB			●	●		In progress
Validation of All-in-One Device for Malaria Diagnosis			●	●		Completed
AI-driven All-in-One Diagnostic platform for Malaria Species Differentiation			●	●		In progress

*WHO licensure prequalification

Diagnostics(Dx)
Project title	Research institute	Development stage
Project title	Research institute	Early Validation	Late Validation	Clinical Validation	Licens-ure
Instrument-free molecular diagnostic platform for COVID-19		●	●
Mobile Diagnostic Platform for Influenza and SARS-CoV-2		●	●
Quantitative POC Test Using mBFPfor G6PD Deficiency		●
Rapid Diagnostic Test for Chikungunya Antigen		●
SurearlySmartPro COVID-19		●
2nd Generation G6PD Test			●	●
Validation of All-in-One Device for Malaria Diagnosis			●	●

*WHO licensure prequalification

Diagnostics(Dx)
Project title	Research institute	Development stage
Project title	Research institute	Early Validation	Late Validation	Clinical Validation	Licens-ure
Leishmaniasis RDT Cartridge and Mobile Pocket Analyzer		●
2nd Generation TB LAM Assay			●	●
AI-driven All-in-One Diagnostic platform for Malaria Species Differentiation			●	●
In vitro Diagnostics Test for Severe Fever and thrombocytopenia Syndrome			●
POCT for Pyrazinamide (PZA) Susceptibility Testing		●
POCT for Multidrug-Resistant TB			●	●

*WHO licensure prequalification

Diagnostics(Dx)
Project title	Research institute	Development stage
Project title	Research institute	Early Validation	Late Validation	Clinical Validation	Licens-ure
Rapid Diagnostic Test for Both S.Typhiand S.ParatyphiA		●	●
Rapid Diagnostic Test for Visceral Leishmaniasis Antigen		●

*WHO licensure prequalification

Digital Health(DH)
Project title	Research institute	Development stage				Current state
Project title	Research institute	Early Validation	Late Validation	Clinical Validation	Licens-ure	Current state
AI-Driven Platform for Anti-Tubercular Drug Discovery		●				Completed
Data Platform to Improve Diagnosis of Infectious Diseases		●				Completed
ICT based Self-risk Assessment Platform for COVID-19		●				Completed
Chest X-ray AI for COVID-19				●		Suspended

*WHO licensure prequalification

Digital Health(DH)
Project title	Research institute	Development stage
Project title	Research institute	Early Validation	Late Validation	Clinical Validation	Licens-ure
Validation of All-in-One Device for Malaria Diagnosis		●
Data Platform to Improve Diagnosis of Infectious Diseases		●
ICT based Self-risk Assessment Platform for COVID-19		●

No information yet.

*WHO licensure prequalification

Digital Health(DH)
Project title	Research institute	Development stage
Project title	Research institute	Early Validation	Late Validation	Clinical Validation	Licens-ure
Chest X-ray AI for COVID-19				●

근거생성 진행
과제명	연구기관	연구지역/국가
산모 및 아동 건강 서비스 분야		우간다
감염병 진단 분야		모잠비크

No information yet.

근거생성 진행
과제명	연구기관	연구지역/국가	현황
산모 및 아동 건강 서비스 분야		우간다	진행
감염병 진단 분야		모장비크	진행

This field should be left blank

Portfolio

Receive newsletters from the RIGHT Foundation by e-mail